| Net Cash Provided by (Used in) Operating Activities |
-26M |
USD |
-7426% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
50.6M |
USD |
-64.9% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-27.6M |
USD |
+83.7% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
2B |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
103M |
shares |
+0.02% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-2.98M |
USD |
+88.3% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
510M |
USD |
+355% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
5.23M |
USD |
-71.9% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
71.7M |
USD |
-17.8% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
4.16M |
USD |
+217% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
244M |
USD |
+342% |
Q4 2023 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
81.9M |
USD |
+310% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
34.1M |
USD |
-12.4% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
6.8M |
shares |
-57.3% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
15.8M |
USD |
+265% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
10.8M |
USD |
+137% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
200M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
-26.5M |
USD |
-109% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
6.8M |
shares |
-57.3% |
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
4M |
USD |
+192% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
-41K |
USD |
-102% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
225M |
USD |
+7.1% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
66.5M |
USD |
-3.08% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
19.5M |
USD |
+531% |
Q3 2025 |
Q3 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
-250K |
USD |
-149% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
187M |
USD |
+20.5% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |